Cancer outcomes and biological mechanisms among patients with type 2 diabetes mellitus using glucagon-like peptide-1 receptor agonists: a systematic review and meta-analysis - Quiz - MDSpire

Cancer outcomes and biological mechanisms among patients with type 2 diabetes mellitus using glucagon-like peptide-1 receptor agonists: a systematic review and meta-analysis

  • By

  • Ejike Daniel Eze

  • Leopold Ntakirutimana

  • Swase Dominic Terkimbi

  • Muluken Walle

  • Abdullahi Hussein Umar

  • Diresibachew Haile Wondimu

  • Makinde Vincent Olubiyi

  • Onyinye Cynthia Okeke

  • Olufunke Onaadepo

  • Jimoh Abdulazeez

  • David Chibuike Ikwuka

  • Elemi John Ani

  • Abdullateef Isiaka Alagbonsi

  • July 14, 2026

Share

Original Source(s)

Cancer outcomes and biological mechanisms among patients with type 2 diabetes mellitus using glucagon-like peptide-1 receptor agonists: a systematic review and meta-analysis

  • by Ejike Daniel Eze, Leopold Ntakirutimana, Swase Dominic Terkimbi, Muluken Walle, Abdullahi Hussein Umar, Diresibachew Haile Wondimu, Makinde Vincent Olubiyi, Onyinye Cynthia Okeke, Olufunke Onaadepo, Jimoh Abdulazeez, David Chibuike Ikwuka, Elemi John Ani, Abdullateef Isiaka Alagbonsi

  • July 14, 2026

Related Content

Case Report: Preoperative embolization for a large intracranial pheochromocytoma metastasis: a novel approach to minimize intraoperative risk

Subepithelial nevus and papilloma of the lacrimal caruncle: a case report and literature review

Late radiation necrosis following stereotactic radiosurgery after COVID-19 vaccination: a case report and hypothesis of immune-mediated inflammatory activation